v3.26.1
Income Taxes - Additional Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Taxes Disclosure [Line Items]    
Increase in valuation allowance $ 24,800,000 $ 24,800,000
Annual taxable income 80.00%  
Orphan drug credit carryforwards $ 7,448,000 2,193,000
Open tax year 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025  
Accrued interest related to uncertain tax positions $ 0  
Accrued penalties related to uncertain tax positions   0
Penalties and interest expense related to income taxes 0 $ 0
Federal    
Income Taxes Disclosure [Line Items]    
Net operating loss carryforwards $ 102,800,000  
Tax credit carryforwards, Expiration year 2044  
Orphan drug credit carryforwards $ 7,500,000  
Federal | Research and Development    
Income Taxes Disclosure [Line Items]    
Tax credit carryforwards $ 1,200,000  
Tax credit carryforwards, Expiration year 2039  
State    
Income Taxes Disclosure [Line Items]    
Net operating loss carryforwards $ 96,900,000  
Net operating loss carryforwards expiration beginning year 2044  
State | Research and Development    
Income Taxes Disclosure [Line Items]    
Tax credit carryforwards $ 200,000  
Tax credit carryforwards, Expiration year 2039